Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici, A.; Emet, SAMİM; Cakmak, R.; YURUYEN, G.; Alibeyoglu, Alpay; AKARSU, M.; ARMAN, Yusuf; Kose, M.; OZGUN, Ersin; OZCAN, M.; ALTUN, O.; Onur, I.; Tukek, TUFAN

doi:10.26355/eurrev_201806_15180

Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ...Daha Fazla

European review for medical and pharmacological sciences, cilt.22, sa.11, ss.3534-3543, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 11
Basım Tarihi: 2018
Doi Numarası: 10.26355/eurrev_201806_15180
Dergi Adı: European review for medical and pharmacological sciences
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.3534-3543
İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.